--Procept BioRobotics initiated with a Buy, $58 price target at Truist 06:35 PRCT
--Arbe Robotics management to meet virtually with MKM Partners 04:55 ARBE Virtual Meeting to be held on October 25 hosted by MKM Partners.
--Lava Therapeutics initiated with a Buy at H.C. Wainwright 06:09 LVTX
--Ouster initiated with a Buy at Rosenblatt 17:48 OUST Rosenblatt analyst Kevin Cassidy initiated coverage of Ouster with a Buy rating and $2 price target. Ouster is a leader in digital LiDAR technology that is currently shipping thousands of units quarterly, Cassidy tells investors in a research note. The analyst expects that the REV7 products, which he says increases performance and double its sellable market, can accelerate Ouster's traction in automotive applications.
--Calix says 'robust' bookings, supply chain outperformance drove Q3 beat 16:16 CALX The company said in its Q3 investor letter: "Robust bookings combined with supply chain outperformance led to the strong results in the quarter. We are seeing an acceleration in the number of new and legacy communication service providers and investors that are looking to become Calix platform-based Broadband Service Providers to simplify their businesses, excite their subscribers and grow their value for their members/investors and local community. The transformation of the service provider marketplace from builders of 'bumb' pipes to providers of a managed experience is gaining momentum and will likely continue for at least the next decade. Our unique platforms -Intelligent Access Edge, Revenue Edge and Calix Cloud - position us perfectly to help this next generation of BSPs succeed."
--Polaris still sees 2022 adjusted EPS $10.10-$10.30, consensus $10.02 06:04 PII
--Polaris reports Q3 adjusted EPS $3.25, consensus $2.82 06:02 PII